C₉H₁₅N₃O₂S
NADPH, short for β-nicotinamide adenine dinucleotide phosphate (reduced form), is also known as sodium reduced coenzyme II-4. It was formerly called pyridine triphosphate nucleotide and is abbreviated as TPN. It acts as a reducing agent and a hydride ion donor.
Release U Health Product Ltd is located in New York City, with a company investment exceeding tens of millions of US dollars. It boasts facilities spanning tens of thousands of square meters that comply with Good Manufacturing Practice (GMP) standards, supporting large-scale production of biosynthetic fermentation ingredients, medicinal extracts, as well as finished products such as soft candies, liquid bars, and tablets.
Its parent company has received support from major investors including Nestlé of Switzerland and Plug and Play. Through collaborations with various universities, the company has established a research and development platform encompassing cell engineering, pilot-scale testing, 30-ton fermentation, and full purification systems, backed by a robust portfolio of patents and intellectual property rights in publications.
